Aurora Cannabis (ACB) EBT (2017 - 2025)

Aurora Cannabis (ACB) has 9 years of EBT data on file, last reported at $17.5 million in Q4 2025.

• EBT for Q4 2025 came in at $17.5 million, down 23.88% year-over-year; the trailing twelve-month figure through Dec 2025 was $17.5 million (up 44.6% YoY), and the FY2025 annual result was $14.2 million, up 133.21% from the prior year.
• EBT climbed to $17.5 million in Q4 2025 per ACB's latest filing, from $5.6 million in the prior quarter.
• Over five years, EBT peaked at $23.0 million in Q4 2024 and troughed at -$795.7 million in Q1 2022.
• A 5-year average of -$91.8 million and a median of -$11.1 million in 2021 frame the typical range for EBT.
• The sharpest annual moves came in 2022 and 2025: EBT plunged 508.96% in 2022, then soared 1172.18% in 2025.
• A 5-year view of EBT shows it stood at -$59.9 million in 2021, then grew by 23.19% to -$46.0 million in 2022, then soared by 72.66% to -$12.6 million in 2023, then surged by 282.5% to $23.0 million in 2024, then slipped by 23.88% to $17.5 million in 2025.
• Business Quant data shows ACB's EBT at $17.5 million in Q4 2025, $5.6 million in Q3 2025, and $333431.2 in Q2 2025.